MeSH D006940 - hyperemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alcon Research | Naphazoline | Naphcon | 1982-01-01 | |||
| Naphazoline, Pheniramine | Naphcon-a | 1994-06-08 | ||||
| Allergan | Naphazoline | Albalon | 1982-01-01 | |||
| Altaire Pharmaceuticals | Naphazoline, Pheniramine | Naphazoline Pheniramine | 2010-09-27 | |||
| Bausch Health Companies | Naphazoline | Nafazair | 1994-05-25 | |||
| Naphazoline | Opcon | 1982-01-01 | ||||
| Naphazoline, Pheniramine | Opcon-a | 1994-06-08 | ||||
| Johnson & Johnson | Naphazoline, Pheniramine | Visine | 1996-01-31 | |||
| Novartis | Naphazoline | Vasocon | 1983-03-24 | |||
| Naphazoline, Antazoline | Vasocon-a | 1994-07-11 | ||||
| Rising Pharmaceuticals | Naphazoline | Naphazoline | 1982-01-01 | |||
| Naphazoline, Pheniramine | Naphazoline Pheniramine | 2013-01-24 |
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
0%0/0
Phase 3
25%1/4
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use